How to prepare racemic epinephrine from epinephrine (Epi) 1:1000 for nebulization in croup treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Preparing Epinephrine 1:1000 for Nebulization in Croup

When racemic epinephrine is unavailable, use L-epinephrine 1:1000 at a dose of 0.5 mL/kg (maximum 5 mL) diluted in normal saline for nebulization in croup. 1, 2

Standard Preparation Protocol

Using L-Epinephrine (1:1000) as Substitute for Racemic Epinephrine

  • Calculate the dose: 0.5 mL/kg of epinephrine 1:1000 solution, with a maximum dose of 5 mL 1, 2
  • Dilute in normal saline: Add the calculated dose to approximately 2-3 mL of normal saline in the nebulizer chamber 3, 4
  • Administer via standard nebulizer: Use a standard jet nebulizer over 10-15 minutes until the medication is fully nebulized 3

Dosing Examples by Weight

  • 10 kg child: 5 mL of epinephrine 1:1000 (already at maximum dose) 1
  • 8 kg child: 4 mL of epinephrine 1:1000 1
  • 6 kg child: 3 mL of epinephrine 1:1000 1

Critical Safety Considerations

Do Not Confuse Formulations

  • Racemic epinephrine 2.25% solution is NOT the same as epinephrine 1:1000 - these are entirely different concentrations requiring different dosing 2
  • If using actual racemic epinephrine 2.25%, the dose is only 0.05 mL/kg (maximum 0.5 mL) diluted in 2 mL normal saline 1, 2
  • Many institutions use a standardized 0.5 mL dose of racemic epinephrine 2.25% for all patients regardless of weight 1, 2

Post-Administration Monitoring Requirements

  • Observe for 2-3 hours after each dose to monitor for symptom rebound, as the effect is short-lived (1-2 hours) 3, 1, 5
  • Do not discharge patients immediately after nebulized epinephrine administration due to risk of rebound symptoms 3, 5
  • Traditional practice recommended admission after 2 doses, but recent evidence supports considering admission only after 3 total doses of epinephrine 3, 1, 5

Clinical Context and Efficacy

Expected Therapeutic Response

  • Significant symptom improvement occurs at 30 minutes post-treatment with reduction in croup scores 6, 7
  • The therapeutic effect is temporary and typically lasts only 1-2 hours 3, 1
  • No significant difference exists between racemic epinephrine and L-epinephrine in clinical efficacy 7

Evidence Supporting L-Epinephrine Substitution

  • L-epinephrine (1:1000) at 0.5 mL/kg is an acceptable substitute when racemic epinephrine is unavailable 1, 2
  • Studies demonstrate equivalent efficacy between racemic and L-epinephrine formulations 7
  • Lower doses (0.1 mg/kg) have been studied and found non-inferior to conventional doses (0.5 mg/kg) in moderate to severe croup 8

Common Pitfalls to Avoid

  • Never use epinephrine for outpatient or home treatment due to short duration of action and potential for rebound 3, 1
  • Do not use 1:10,000 epinephrine concentration - this is for cardiac arrest, not nebulization 2
  • Avoid premature discharge before completing the 2-3 hour observation period 5
  • Always administer corticosteroids concurrently - oral dexamethasone 0.6 mg/kg should be given to all croup patients regardless of severity 5, 4

References

Guideline

Racemic Epinephrine Administration and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Racemic Epinephrine Concentration for Croup

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Croup with Nebulization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nebulized racemic epinephrine by IPPB for the treatment of croup: a double-blind study.

American journal of diseases of children (1960), 1978

Research

Nebulized epinephrine for croup in children.

The Cochrane database of systematic reviews, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.